Stakeholder engagement and pharmaceutical pricing regulation: a qualitative inquiry.

ABSTRACT:

Background

Medicine affordability is a critical component of a country's redistributive health policies aimed at ensuring equitable access to healthcare. This study aims to investigate key stakeholders' perspectives on pharmaceutical pricing control in Malaysia as the country is moving towards sustainable healthcare.

Methods

Semi-structured interviews (n = 16) were conducted with a purposive sampling of key stakeholders, which included practitioners and policymakers engaged in Malaysia's public health policy. Data were analysed using thematic analysis guided by Walt and Gilson's [(1994). Reforming the health sector in developing countries: The central role of policy analysis. Health Policy and Planning, 9(4), 353-370. https://doi.org/10.1093/heapol/9.4.3

SUBMITTER: Loh YSL 

PROVIDER: S-EPMC12416026 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature